Medicine
Dificid 200 mg tablet
Dificid 200 mg tablet is a prescription medicine containing Fidaxomicin for oral use, marketed by Merck Sharp & Dohme, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store DIFICID tablets at 20°C-25°C (68°F-77°F), excursions permitted to…
Key facts
- Active ingredient (INN)
- Fidaxomicin
- Brand
- Dificid
- Strength
- 200 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 1 bottle
- Marketing authorisation holder
- Merck Sharp & Dohme
- Manufacturer
- Merck Sharp & Dohme
- Origin register
- US FDA, United States
- Storage
- Store DIFICID tablets at 20°C-25°C (68°F-77°F), excursions permitted to 15°C-30°C (59°F-86°F). See USP controlled room temperature. Granules for oral suspension Store DIFICID granules for oral suspension at 20°C-25°C (68°F-77°F), excursions permitted to 15°C-30°C (59°F-86°F). Store in the original bottle. Store in the original package.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A07AA12 Fidaxomicin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 May 2011
- Identifiers
- RxCUI 1111106, 1111110, 2279843 +1DailyMed set ID dd966338-c820-4270-b704-09ef75fa3cebNDC 52015-080Application NDA201699
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 20 tablet, film coated in 1 bottle | 52015-080-01 | Merck Sharp & Dohme | 27 May 2011 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Fidaxomicin 200 mg tablet.
Other strengths and forms of Fidaxomicin
Clinical summary
Fidaxomicin is a macrolide antibacterial indicated in adult and pediatric patients 6 months of age and older for the treatment of C. difficile -associated diarrhea, among other approved uses. It is available as tablets and oral suspension. MedsAcross supplies Fidaxomicin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about FidaxomicinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Dificid prescribing information (Merck Sharp & Dohme) · U.S. National Library of Medicine, DailyMed
- Dificlir: European public assessment report (EPAR) · European Medicines Agency
Need Dificid 200 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.